SCHEMBL30147485

SCHEMBL30147485

CNC(=O)c1cc2c(C(F)F)cc(F)cc2[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.40
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
EIF4A3 P38919 1/20 0.38
CNR1 P21554 1/20 0.35
NUDT1 P36639 2/20 0.34
FBP1 P09467 1/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
AR P10275 1/20 0.34
MLLT1 Q03111 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
CREBBP Q92793 1/20 0.33
KDM4E B2RXH2 1/20 0.33
IDO1 P14902 1/20 0.33
TDO2 P48775 1/20 0.33
FLT3 P36888 1/20 0.33
PTPN11 Q06124 1/20 0.33
TLR8 Q9NR97 1/20 0.32
TLR7 Q9NYK1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30147505 0.87 EIF4A3 (0.40) ALOX15KMT2AMEN1EIF4A3CNR1
SCHEMBL22395014 0.82 EIF4A3 (0.51) KMT2AMEN1EIF4A3KDM4EIDO1
SCHEMBL18183345 0.82 CNR1 (0.48) ALOX15KMT2AMEN1EIF4A3CNR1
SCHEMBL29465482 0.82 EIF4A3 (0.51) KMT2AMEN1EIF4A3KDM4EIDO1
SCHEMBL30147453 0.81 NPC1 (0.48) ALOX15KMT2AMEN1EIF4A3CNR1
SCHEMBL30147479 0.80 ALOX15 (0.43) ALOX15KMT2AMEN1NUDT1NPC1
SCHEMBL30147558 0.78 KMT2A (0.43) ALOX15KMT2AMEN1EIF4A3CNR1
SCHEMBL30147623 0.77 ALOX15 (0.40) ALOX15KMT2AMEN1EIF4A3CNR1
SCHEMBL22647644 0.77 KDM4E (0.46) ALOX15KMT2AMEN1NPC1RAB9A
SCHEMBL30147459 0.75 EIF4A3 (0.57) ALOX15KMT2AMEN1EIF4A3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF ARBUTUS BIOPHARMA CORP (CA) 2023-10-05 US disclosed
CN-115551864-A Substituted tricyclic amides, analogs thereof, and methods of using the same 爱彼特生物制药公司 2022-12-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF NSD3, PML, NSD1 ALOX15 4456/4885KMT2A 201/4885MEN1 2151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.